Bristol's Eliquis approved to prevent clots after hip, knee surgery
March 14, 2014 at 13:17 PM EDT
March 14 (Reuters) - U.S. regulators have approved an additional use of Bristol-Myers Squibb Co's blood clot preventer Eliquis, to prevent blood clots in the legs and lungs of patients who have undergone surgery to receive artificial hips or knees.